ONTTF News and Press, Oxford Nanopore From 02/15/23

Summary Singular Genomics Systems is a unique opportunity to invest in a commercially-viable startup at the forefront of a rapidly expanding field. The company has adequate funding to maintain its current level of commercialization and sales activity for a few years. Capital gains c...

Summary Oxford Nanopore is well-positioned to take advantage of the growing demand for DNA sequencing services and capture a growing share of the market. The company is developing innovative, affordable, and cost-effective sequencing technologies that will fuel the growth of third-gener...

Summary The gene sequencing market is ripe for disruption. ILMN suffers from multiple strategic setbacks that will likely impact margins for years. Oxford Nanopore and Pacific Biosciences will likely grow at a faster pace than ILMN. The industry trades at high price multiples. ...

Summary On October 31, the company announced an agreement to streamline the company’s capital structure. The company expects a Book Value of $5.37. The private portfolio's value is higher than the cost. Acacia: the long case is broken but there is still value ...

Summary PACB's management believes that it is the only sequencing technology company offering HiFi reads with a 99.9% accuracy. Sequel II systems realized higher selling prices including a multi-instrument order with greater consumable service revenue volume in Q2 2022. PACB i...

The following slide deck was published by Oxford Nanopore Technologies plc in conjunction with their 2022 Q2 earnings call. For further details see: Oxford Nanopore Technologies plc 2022 Q2 - Results - Earnings Call Presentation

Oxford Nanopore Technologies plc (ONTTF) Q2 2022 Results Conference Call September 13, 2022 07:00 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Tim Cowper - Chief Financial Officer Conference Call Participants Odysseas Manesiotis - ...

Oxford Nanopore press release ( OTCPK:ONTTF ): 1H GAAP EPS of 4p. Revenue of £122.3M (+107.3% Y/Y). For further details see: Oxford Nanopore reports 1H results

Recent volatility mirror renewed meme-trade bonanza, likely to subdue in coming days, instead of a reflection of a change in the company's market position. Several factors distorted the YoY revenue comparison this quarter, contributing to the inflated top-line growth, including the Bi...

Oxford Nanopore integrates "Remora": a tool to enable real-time, high-accuracy epigenetic insights with nanopore sequencing software MinKNOW Oxford Nanopore has today released Remora, a high-performance tool for methylation analysis, into its operating software, MinKNOW, broadening ...